These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29414125)

  • 21. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fundamental evaluation and optimization of porous spherical silica for developing functional fine particles via fluidized bed coating.
    Taki H; Kobashi A; Ishida M; Otsuka M
    Int J Pharm; 2019 Nov; 571():118685. PubMed ID: 31513873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Dissolution Data Integrated in Tablet Database Using Four-Layered Artificial Neural Networks.
    Takayama K; Kawai S; Obata Y; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2017; 65(10):967-972. PubMed ID: 28966281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
    Capece M; Huang Z; Davé R
    J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High loading of lipophilic compounds in mesoporous silica for improved solubility and dissolution performance.
    Benedikt Brenner M; Wüst M; Kuentz M; Wagner KG
    Int J Pharm; 2024 Apr; 654():123946. PubMed ID: 38417728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An exact model for predicting tablet and blend content uniformity based on the theory of fluctuations in mixtures.
    Rane SS; Hamed E; Rieschl S
    J Pharm Sci; 2012 Dec; 101(12):4501-15. PubMed ID: 22987282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.
    Perumalla SR; Sun CC
    J Pharm Sci; 2014 Apr; 103(4):1126-32. PubMed ID: 24515970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silica-based systems for oral delivery of drugs, macromolecules and cells.
    Diab R; Canilho N; Pavel IA; Haffner FB; Girardon M; Pasc A
    Adv Colloid Interface Sci; 2017 Nov; 249():346-362. PubMed ID: 28473052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Characterization of Liquisolid Tablets Based on Mesoporous Clays or Silicas for Improving Glyburide Dissolution.
    Cirri M; Mura P; Valleri M; Brunetti L
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32492869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Adsorption State and Molecular Interaction on Physical Stability of Confined Amorphous Vortioxetine.
    Cao Y; Zhang K; Wang M; Gao Z; Wang J; Gong J
    Mol Pharm; 2021 Jul; 18(7):2754-2763. PubMed ID: 34152780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation.
    Price DJ; Nair A; Becker-Baldus J; Glaubitz C; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2020 Jan; 141():105113. PubMed ID: 31655207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming powder mechanical properties by core/shell structure: compressible sand.
    Shi L; Sun CC
    J Pharm Sci; 2010 Nov; 99(11):4458-62. PubMed ID: 20845444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties.
    Shen SC; Ng WK; Chia L; Dong YC; Tan RB
    J Pharm Sci; 2010 Apr; 99(4):1997-2007. PubMed ID: 19816955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel.
    Sawicki E; Beijnen JH; Schellens JH; Nuijen B
    Int J Pharm; 2016 Sep; 511(2):765-73. PubMed ID: 27480397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-step Coprocessing of Cohesive Powder via Mechanical Dry Coating for Direct Tablet Compression.
    Qu L; Stewart PJ; Hapgood KP; Lakio S; Morton DAV; Zhou QT
    J Pharm Sci; 2017 Jan; 106(1):159-167. PubMed ID: 27665128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release.
    Järvinen MA; Paaso J; Paavola M; Leiviskä K; Juuti M; Muzzio F; Järvinen K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1802-8. PubMed ID: 23163644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.